Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/08/2007CA2649590A1 Mono and combination therapy with m1/m4 muscarinic agonist (sabcomeline) for treatment of prodromal syndrome
11/08/2007CA2649577A1 Benzamide glucokinase activators
11/08/2007CA2649471A1 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
11/08/2007CA2649432A1 Antifungal agents
11/08/2007CA2649363A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitor activity
11/08/2007CA2649349A1 Spirocyclic cyclohexane derivatives having an analgesic action
11/08/2007CA2649335A1 Pharmaceutical composition containing a taxane derivative, destined for the preparation of an infusion solution, method of preparation thereof and use thereof
11/08/2007CA2649243A1 An osmotic drug delivery system
11/08/2007CA2649111A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2648986A1 Use of a dermatological composition comprising a combination of hydroquinone, fluocinolone acetonide and tretinoin, for treating hyperpigmentation of pathological scars
11/08/2007CA2648898A1 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
11/08/2007CA2648884A1 Abnormal cannabidiols as agents for lowering intraocular pressure
11/08/2007CA2648236A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2648139A1 Diaryl thiohydantoin compounds and their use in the treatment of hyperproliferative disorders
11/08/2007CA2648124A1 Kinase inhibitors
11/08/2007CA2648086A1 Methods and compositions for inducing an immune response to hiv and models for testing
11/08/2007CA2648019A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2647949A1 P38 inhibitors and methods of use thereof
11/08/2007CA2647933A1 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
11/08/2007CA2647678A1 Diazepan orexin receptor antagonists
11/08/2007CA2647543A1 Inhibition of alpha-synuclein toxicity
11/08/2007CA2647338A1 Integrase inhibitors-3
11/08/2007CA2646624A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007CA2646196A1 Dietary supplements containing probiotics
11/08/2007CA2646048A1 Compositions and methods of use for antibodies of c-met
11/08/2007CA2644819A1 Process for preparing memantine hydrochloride substantially free of impurities
11/08/2007CA2637766A1 Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
11/08/2007CA2634871A1 Treatment of renal disorders, diabetic nephopathy and dyslipidemias
11/08/2007CA2617878A1 Topical drug delivery by iontophoresis
11/07/2007EP1852506A2 Lipophilic derivatives of double-stranded ribonucleic acid
11/07/2007EP1852505A1 Mutations in ion channels
11/07/2007EP1852503A1 Il-13 production inhibitor
11/07/2007EP1852499A1 Neurotization promoting agent
11/07/2007EP1852439A1 Spiroketal derivative and use thereof as diabetic medicine
11/07/2007EP1852437A2 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
11/07/2007EP1852436A1 Process for production of carbapenem derivative and crystalline intermediate therefor
11/07/2007EP1852435A1 A process for the manufacture of famciclovir using phase-transfer catalysts
11/07/2007EP1852434A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity
11/07/2007EP1852433A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1852431A1 Optically active tetrahydronaphthalene derivative
11/07/2007EP1852427A1 Biologically active 4H-Benzo [1,4] oxazin-3-ones
11/07/2007EP1852426A1 Process for production of optically active ppar-activating compound and intermediate of the same
11/07/2007EP1852423A1 Crystal of 4(3h)-quinazolinone derivative
11/07/2007EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007EP1852420A1 Indole compound and use thereof
11/07/2007EP1852178A1 Process for producing coated fine particle
11/07/2007EP1852130A1 Medicine for external application containing anti-inflammatory agent and soy lecithin
11/07/2007EP1852129A1 Remedy for irritable bowel syndrome
11/07/2007EP1852128A1 An anti HSP90 antibody
11/07/2007EP1852127A1 Use of a B-cell-depleting antibody for treatment of polyoma virus infections
11/07/2007EP1852123A2 Activation and inhibition of the immune system
11/07/2007EP1852121A2 Lipid analogs for treating viral infections
11/07/2007EP1852120A1 Ointment
11/07/2007EP1852119A1 Pharmaceutical composition containing phenoxazinium compound as active ingredient
11/07/2007EP1852118A1 Method for producing adsorptive porous body
11/07/2007EP1852117A1 Pharmaceutical agent comprising solifenacin
11/07/2007EP1852116A1 Pharmaceutical compositions of amlodipine and atorvastatin
11/07/2007EP1852115A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
11/07/2007EP1852114A1 COMPOSITION CONTAINING DIHOMO-(gamma)-LINOLENIC ACID (DGLA) AS THE ACTIVE INGREDIENT
11/07/2007EP1852113A2 Methods for treating neuropsychiatric disorders with NMDA receptors antagonists
11/07/2007EP1852112A1 Anti-tumor agent
11/07/2007EP1852111A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
11/07/2007EP1852109A1 Xylitol granules capable of directly being pressed into tablets and preparation process thereof
11/07/2007EP1852100A1 Method for producing granules
11/07/2007EP1851739A2 Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto
11/07/2007EP1851549A2 Pharmaceutical compositions for the treatment of prostate cancer
11/07/2007EP1851307A1 Method of treatment by administration of rna
11/07/2007EP1851240A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
11/07/2007EP1851236A2 Macrolides with anti-inflammatory activity
11/07/2007EP1851234A1 Substituted propane phosphinic acid esters
11/07/2007EP1851232A2 Dihydroimidazothiazole derivatives
11/07/2007EP1851231A2 Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
11/07/2007EP1851230A1 Tetrahydropyridothiophenes as antripoliferative agents for the treatment of cancer
11/07/2007EP1851229A1 Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
11/07/2007EP1851228A1 Pyrimidothiophene compounds having hsp90 inhibitory activity
11/07/2007EP1851227A1 An efficient and stereoselective process for large scale synthesis of 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-one
11/07/2007EP1851226A1 Method for purifying noroxymorphone compounds
11/07/2007EP1851225A1 Pyrazolo-pyrimidine derivatives as mglur2 antagonists
11/07/2007EP1851224A2 Hydroxyalkyl substituted imidazoquinolines
11/07/2007EP1851221A1 Tadalafil having a large particle size and a process for preparation thereof
11/07/2007EP1851220A2 Hydroxyalkyl substituted imidazonaphthyridines
11/07/2007EP1851219A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase
11/07/2007EP1851218A2 Hydroxyalkyl substituted imidazoquinoline compounds and methods
11/07/2007EP1851217A1 Substituted pyrido(2,3-d)pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders
11/07/2007EP1851216A2 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
11/07/2007EP1851214A1 Isoxazoline derivative and novel process for its preparation
11/07/2007EP1851213A2 Mitotic kinesin inhibitors
11/07/2007EP1851210A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
11/07/2007EP1851209A2 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
11/07/2007EP1851205A2 Pyridazine derivatives and their use as therapeutic agents
11/07/2007EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
11/07/2007EP1851203A2 Inhibitors of checkpoint kinases
11/07/2007EP1851202A1 Pyridyl acetic acid compounds
11/07/2007EP1851201A1 1-{4-[(1-cyclobutyl-4-piperidinyl)oxy]phenyl}-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine as histamine h3 antagonist
11/07/2007EP1851200A2 Dimeric iap inhibitors
11/07/2007EP1851198A1 Substituted pyrroles, compositions containing same, method for making same and use thereof
11/07/2007EP1851197A2 Phenylazetidinone derivatives
11/07/2007EP1851195A1 Process for preparation of probucol derivatives
11/07/2007EP1851194A1 Process for preparation of probucol derivatives
1 ... 3513 3514 3515 3516 3517 3518 3519 3520 3521 3522 3523 3524 3525 3526 3527 3528 3529 3530 3531 3532 3533 ... 7860